These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 36804635)
1. Genome editing, a superior therapy for inherited retinal diseases. Yan AL; Du SW; Palczewski K Vision Res; 2023 May; 206():108192. PubMed ID: 36804635 [TBL] [Abstract][Full Text] [Related]
2. Future Perspectives of Prime Editing for the Treatment of Inherited Retinal Diseases. Hansen S; McClements ME; Corydon TJ; MacLaren RE Cells; 2023 Jan; 12(3):. PubMed ID: 36766782 [TBL] [Abstract][Full Text] [Related]
3. Gene editing prospects for treating inherited retinal diseases. Benati D; Patrizi C; Recchia A J Med Genet; 2020 Jul; 57(7):437-444. PubMed ID: 31857428 [TBL] [Abstract][Full Text] [Related]
4. Potential of Gene Editing and Induced Pluripotent Stem Cells (iPSCs) in Treatment of Retinal Diseases. Chuang K; Fields MA; Del Priore LV Yale J Biol Med; 2017 Dec; 90(4):635-642. PubMed ID: 29259527 [TBL] [Abstract][Full Text] [Related]
5. The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases. Peddle CF; MacLaren RE Yale J Biol Med; 2017 Dec; 90(4):533-541. PubMed ID: 29259519 [TBL] [Abstract][Full Text] [Related]
6. Genome Surgery and Gene Therapy in Retinal Disorders. Chan L; Mahajan VB; Tsang SH Yale J Biol Med; 2017 Dec; 90(4):523-532. PubMed ID: 29259518 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic Genome Editing and In Vivo Delivery. Ramirez-Phillips AC; Liu D AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099 [TBL] [Abstract][Full Text] [Related]
8. Precision genome editing in the eye. Suh S; Choi EH; Raguram A; Liu DR; Palczewski K Proc Natl Acad Sci U S A; 2022 Sep; 119(39):e2210104119. PubMed ID: 36122230 [TBL] [Abstract][Full Text] [Related]
9. Gene therapy and genome surgery in the retina. DiCarlo JE; Mahajan VB; Tsang SH J Clin Invest; 2018 Jun; 128(6):2177-2188. PubMed ID: 29856367 [TBL] [Abstract][Full Text] [Related]
10. Advancements in pre-clinical development of gene editing-based therapies to treat inherited retinal diseases. Chirco KR; Martinez C; Lamba DA Vision Res; 2023 Aug; 209():108257. PubMed ID: 37210864 [TBL] [Abstract][Full Text] [Related]
11. Challenges to Gene Editing Approaches in the Retina. Bonillo M; Pfromm J; Fischer MD Klin Monbl Augenheilkd; 2022 Mar; 239(3):275-283. PubMed ID: 35316854 [TBL] [Abstract][Full Text] [Related]
12. In vivo application of base and prime editing to treat inherited retinal diseases. Jo DH; Bae S; Kim HH; Kim JS; Kim JH Prog Retin Eye Res; 2023 May; 94():101132. PubMed ID: 36241547 [TBL] [Abstract][Full Text] [Related]
13. CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases. Rasoulinejad SA; Maroufi F Mol Biotechnol; 2021 Sep; 63(9):768-779. PubMed ID: 34057656 [TBL] [Abstract][Full Text] [Related]
14. RNA editing as a therapeutic approach for retinal gene therapy requiring long coding sequences. Fry LE; Peddle CF; Barnard AR; McClements ME; MacLaren RE Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991730 [TBL] [Abstract][Full Text] [Related]
15. Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy. Sanjurjo-Soriano C; Kalatzis V Neural Plast; 2018; 2018():5056279. PubMed ID: 29853845 [TBL] [Abstract][Full Text] [Related]
16. Genome-Editing Strategies for Treating Human Retinal Degenerations. Quinn J; Musa A; Kantor A; McClements ME; Cehajic-Kapetanovic J; MacLaren RE; Xue K Hum Gene Ther; 2021 Mar; 32(5-6):247-259. PubMed ID: 32993386 [TBL] [Abstract][Full Text] [Related]
17. Genome editing: the breakthrough technology for inherited retinal disease? Smith AJ; Carter SP; Kennedy BN Expert Opin Biol Ther; 2017 Oct; 17(10):1245-1254. PubMed ID: 28695744 [TBL] [Abstract][Full Text] [Related]
18. Gene editing technology: Towards precision medicine in inherited retinal diseases. Ballios BG; Pierce EA; Huckfeldt RM Semin Ophthalmol; 2021 May; 36(4):176-184. PubMed ID: 33621144 [No Abstract] [Full Text] [Related]
19. CRISPR in the Retina: Evaluation of Future Potential. Cho GY; Justus S; Sengillo JD; Tsang SH Adv Exp Med Biol; 2017; 1016():147-155. PubMed ID: 29130158 [TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-mediated gene editing. A promising strategy in hematological disorders. Ugalde L; Fañanas S; Torres R; Quintana-Bustamante O; Río P Cytotherapy; 2023 Mar; 25(3):277-285. PubMed ID: 36610813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]